LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $5,962,000 | -23.1% | 42,564 | -6.3% | 0.01% | -9.1% |
Q3 2018 | $7,757,000 | +5.7% | 45,410 | +7.3% | 0.01% | 0.0% |
Q2 2018 | $7,340,000 | +70.1% | 42,310 | +13.1% | 0.01% | +57.1% |
Q1 2018 | $4,316,000 | +74.9% | 37,410 | +27.6% | 0.01% | +75.0% |
Q4 2017 | $2,467,000 | +126.7% | 29,310 | +148.2% | 0.00% | +100.0% |
Q3 2017 | $1,088,000 | +39.7% | 11,810 | +21.6% | 0.00% | +100.0% |
Q2 2017 | $779,000 | – | 9,710 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |